These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37058941)

  • 1. A new strategy for searching determinants in colorectal cancer progression through whole-part relationship combined with multi-omics.
    Xing F; Zheng R; Liu B; Huang K; Wang D; Su R; Feng S
    Talanta; 2023 Jul; 259():124543. PubMed ID: 37058941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Correlative Strategy To Discover Colorectal Tumor Tissue Derived Metabolite Biomarkers in Plasma Using Untargeted Metabolomics.
    Wang Z; Cui B; Zhang F; Yang Y; Shen X; Li Z; Zhao W; Zhang Y; Deng K; Rong Z; Yang K; Yu X; Li K; Han P; Zhu ZJ
    Anal Chem; 2019 Feb; 91(3):2401-2408. PubMed ID: 30580524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Untangling determinants of gut microbiota and tumor immunologic status through a multi-omics approach in colorectal cancer.
    Zhang SL; Cheng LS; Zhang ZY; Sun HT; Li JJ
    Pharmacol Res; 2023 Feb; 188():106633. PubMed ID: 36574857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision medicine in colorectal cancer: Leveraging multi-omics, spatial omics, and artificial intelligence.
    Xu Z; Li W; Dong X; Chen Y; Zhang D; Wang J; Zhou L; He G
    Clin Chim Acta; 2024 Jun; 559():119686. PubMed ID: 38663471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
    Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
    Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated analysis of multi-omics data for the discovery of biomarkers and therapeutic targets for colorectal cancer.
    Zafari N; Bathaei P; Velayati M; Khojasteh-Leylakoohi F; Khazaei M; Fiuji H; Nassiri M; Hassanian SM; Ferns GA; Nazari E; Avan A
    Comput Biol Med; 2023 Mar; 155():106639. PubMed ID: 36805214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer.
    Mokgautsi N; Kuo YC; Chen CH; Huang YJ; Wu ATH; Huang HS
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LC-MS-based lipid profile in colorectal cancer patients: TAGs are the main disturbed lipid markers of colorectal cancer progression.
    Liu T; Peng F; Yu J; Tan Z; Rao T; Chen Y; Wang Y; Liu Z; Zhou H; Peng J
    Anal Bioanal Chem; 2019 Aug; 411(20):5079-5088. PubMed ID: 31201454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A plasma microRNA panel for early detection of colorectal cancer.
    Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
    Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mixed integer programming for multi-biomarker panel identification by distinguishing malignant from benign colorectal tumors.
    Zou M; Zhang PJ; Wen XY; Chen L; Tian YP; Wang Y
    Methods; 2015 Jul; 83():3-17. PubMed ID: 25980368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer screening and diagnosis: omics-based technologies for development of a non-invasive blood-based method.
    Gallardo-Gómez M; De Chiara L; Álvarez-Chaver P; Cubiella J
    Expert Rev Anticancer Ther; 2021 Jul; 21(7):723-738. PubMed ID: 33507120
    [No Abstract]   [Full Text] [Related]  

  • 12. Integrated multi-omics approach to distinct molecular characterization and classification of early-onset colorectal cancer.
    Du M; Gu D; Xin J; Peters U; Song M; Cai G; Li S; Ben S; Meng Y; Chu H; Chen L; Wang Q; Zhu L; Fu Z; Zhang Z; Wang M
    Cell Rep Med; 2023 Mar; 4(3):100974. PubMed ID: 36921601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
    Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine Learning-Based Integrated Multiomics Characterization of Colorectal Cancer Reveals Distinctive Metabolic Signatures.
    Zheng R; Su R; Fan Y; Xing F; Huang K; Yan F; Chen H; Liu B; Fang L; Du Y; Zhou F; Wang D; Feng S
    Anal Chem; 2024 May; 96(21):8772-8781. PubMed ID: 38743842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges.
    Das V; Kalita J; Pal M
    Biomed Pharmacother; 2017 Mar; 87():8-19. PubMed ID: 28040600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-omics analyses of human colorectal cancer revealed three mitochondrial genes potentially associated with poor outcomes of patients.
    Zhang W; Lin L; Xia L; Cai W; Dai W; Zou C; Yin L; Tang D; Xu Y; Dai Y
    J Transl Med; 2021 Jun; 19(1):273. PubMed ID: 34174878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omics technologies for improved diagnosis and treatment of colorectal cancer: Technical advancement and major perspectives.
    Dalal N; Jalandra R; Sharma M; Prakash H; Makharia GK; Solanki PR; Singh R; Kumar A
    Biomed Pharmacother; 2020 Nov; 131():110648. PubMed ID: 33152902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oleic acid-induced NOX4 is dependent on ANGPTL4 expression to promote human colorectal cancer metastasis.
    Shen CJ; Chang KY; Lin BW; Lin WT; Su CM; Tsai JP; Liao YH; Hung LY; Chang WC; Chen BK
    Theranostics; 2020; 10(16):7083-7099. PubMed ID: 32641980
    [No Abstract]   [Full Text] [Related]  

  • 19. Revelation of Proteomic Indicators for Colorectal Cancer in Initial Stages of Development.
    Kopylov AT; Stepanov AA; Malsagova KA; Soni D; Kushlinsky NE; Enikeev DV; Potoldykova NV; Lisitsa AV; Kaysheva AL
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32023884
    [No Abstract]   [Full Text] [Related]  

  • 20. A pilot study of new promising non-coding RNA diagnostic biomarkers for early-stage colorectal cancers.
    Liu H; Ye D; Chen A; Tan D; Zhang W; Jiang W; Wang M; Zhang X
    Clin Chem Lab Med; 2019 Jun; 57(7):1073-1083. PubMed ID: 30978169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.